Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.

BACKGROUND: Staphylococcus aureus bacteraemia is a common and serious infection, with an associated mortality of ~25%. Once in the blood, S. aureus can disseminate to infect almost any organ, but bones, joints and heart valves are most frequently affected. Despite the infection's severity, the...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Thwaites, G, Auckland, C, Barlow, G, Cunningham, R, Davies, G, Edgeworth, J, Greig, J, Hopkins, S, Jeyaratnam, D, Jenkins, N, Llewelyn, M, Meisner, S, Nsutebu, E, Planche, T, Read, R, Scarborough, M, Soares, M, Tilley, R, Török, M, Williams, J, Wilson, P, Wyllie, S, Walker, A
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2012

Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.

Míreanna comhchosúla